York Bridge Wealth Partners, LLC Gilead Sciences, Inc. Transaction History

York Bridge Wealth Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $55,212 - $72,048	-912 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $12,382 - $15,096	-170 Reduced 15.71%	912 $69,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $33,867 - $39,755	-476 Reduced 30.55%	1,082 $85,000
Q3 2017 Oct 27, 2017	SELL	$72.11 - $85.47 $88,334 - $104,700	-1,225 Reduced 44.02%	1,558 $126,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,783	2,783 $197,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.